Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose- and non-glucose-induced insulin secretion in patients with type 2 diabetes mellitus

Kasper Aaboe, Filip Krag Knop, Tina Vilsbøll, Carolyn F. Deacon, Jens Juul Holst, Sten Madsbad, Thure Krarup

93 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose- and non-glucose-induced insulin secretion in patients with type 2 diabetes mellitus'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab